MarketCapTrends
VRDN

Viridian Therapeutics Inc. (VRDN)

NASDAQ · Healthcare

Viridian Therapeutics Inc. annual/quarterly total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Viridian Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 177.3M, a 150.48% increase year-over-year.
  • Viridian Therapeutics Inc. total liabilities for 2025 were 177.3M, a 150.48% increase from 2024.
  • Viridian Therapeutics Inc. total liabilities for 2024 were 70.8M, a 46.20% increase from 2023.
  • Viridian Therapeutics Inc. total liabilities for 2023 were 48.4M, a 20.92% increase from 2022.
  • Viridian Therapeutics Inc. total liabilities for 2022 were 40.0M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Viridian Therapeutics Inc. Annual Total Liabilities (Millions of US $)
2025$177
2024$71
2023$48
2022$40
2021$16
2020$11
2019$15
2018$15
2017$14
2016$10
Viridian Therapeutics Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$177
2024-12-31$71
2023-12-31$48
2022-12-31$40
2021-12-31$16
2020-12-31$11
2019-12-31$15
2018-12-31$15
2017-12-31$14
2016-12-31$10

Viridian Therapeutics Inc. Total Liabilities — FAQ

Viridian Therapeutics Inc. (VRDN) total liabilities over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VRDN's total liabilities history?

The chart and table above show Viridian Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.